XML 74 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 513.7 $ 498.5 $ 1,523.9 $ 1,522.5
Cost of products sold 414.3 404.9 1,248.2 1,236.0
Gross profit 99.4 93.6 275.7 286.5
Selling and general expense 53.7 54.3 174.2 181.0
Research and development expense 5.6 5.7 18.6 17.5
Intangible asset amortization expense 16.0 15.4 47.3 46.9
Total nonmanufacturing expenses 75.3 75.4 240.1 245.4
Goodwill impairment expense 0.0 0.0 411.9 0.0
Restructuring and other impairment expense 8.1 11.2 18.2 37.4
Operating profit (loss) 16.0 7.0 (394.5) 3.7
Interest expense 17.7 18.3 54.1 55.0
Other expense, net (3.9) (12.7) (4.2) (12.1)
Loss before income taxes (5.6) (24.0) (452.8) (63.4)
Income tax benefit, net (2.4) (3.2) (14.6) (13.2)
Net loss $ (3.2) $ (20.8) $ (438.2) $ (50.2)
Net loss per share:        
Basic (in dollars per share) $ (0.06) $ (0.38) $ (8.04) $ (0.93)
Diluted (in dollars per share) $ (0.06) $ (0.38) $ (8.04) $ (0.93)
Weighted average shares outstanding:        
Basic (in shares) 54,671,900 54,327,500 54,582,100 54,305,800
Diluted (in shares) 54,671,900 54,327,500 54,582,100 54,305,800